查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1549708

藥品包裝：市場佔有率分析、產業趨勢與統計、成長預測（2024-2029）

Pharmaceutical Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 201 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

藥品包裝市場規模預計到2024年為1,021億美元，預計到2029年將達到1,372.8億美元，在預測期內（2024-2029年）複合年成長率為6.10%。

醫藥包裝市場

主要亮點

  • 製藥業在全球範圍內不斷發展，產生了對治療傳染性和非傳染性疾病的包裝的需求。因此，對保護藥品免受損壞、生物污染和外部影響的包裝的需求不斷成長。
  • 藥品需求的成長與產業技術進步有關，這直接創造了對瓶子、管瓶和其他包裝解決方案的需求。此外，對注射劑的需求不斷成長正在推動製藥業管瓶的成長。對癌症藥物和其他高藥理活性藥物（例如抗體偶聯物和速效類固醇）的強勁需求以及人均藥物支出的增加預計將成為關鍵促進因素。
  • 全球藥品需求情境支持了包裝產業的產生收入，預計在預測期內將持續下去。總體而言，由於藥品包裝的不斷擴張和研發改進，藥品包裝市場預計將錄得穩定成長。因此，預計在預測期內需求將大幅增加。
  • 塑膠包裝產業正面臨聚合物成本上漲的問題，使得塑膠變得更加昂貴。此外，烏克蘭和俄羅斯之間的戰爭正在再次推高價格。塑膠及塑膠製品的需求逐年增加。供不應求跟上不斷成長的需求也是聚合物價格上漲的一個因素，預計將阻礙市場成長。
  • 由於 COVID-19 的傳播，預計該市場將大幅成長。由於新冠肺炎 (COVID-19) 疫情的爆發，顧客已轉向線上購買。 COVID-19大流行對開發中國家的包裝材料擴張造成了重大打擊。然而，對無菌藥品包裝的強勁需求鼓勵了對該領域的投資。此外，業內相關人員預計醫療產業對封裝技術將表現出強勁的需求。

醫藥包裝市場趨勢

塑膠包裝佔有很大的市場佔有率

  • 塑膠是最受歡迎的藥品包裝材料之一，因為它用途廣泛、耐用、靈活且永續。藥品包裝使用由多種材料製成的塑膠瓶，包括聚氯乙烯、聚乙烯、聚丙烯和聚苯乙烯。該行業使用透明、耐用且輕質的塑膠來儲存和分配。
  • 塑膠用於包裝泡殼包裝、小袋、預填充式注射器和吸入器、注射液袋和瓶子。用於藥品包裝的材料必須具有化學惰性、水蒸氣滲透性低且易於處理。此外，包裝材料與藥品和生物製藥直接接觸，必須遵守監管機構的嚴格規定。塑膠和聚合物滿足這些要求，因此經常用於藥品包裝。
  • 藥品包裝瓶由防兒童開啟的瓶蓋和封口組成。美國FDA要求藥用塑膠製造商在產品標籤上標示「兒童安全包裝」聲明，以獲得消費者認可。對兒童安全包裝的需求不斷成長是預測期內推動醫藥塑膠包裝市場的因素之一。
  • 作為利用藥品包裝的一部分，公司正專注於擴大業務。例如，2024 年 9 月，德國醫療保健包裝公司 Sanner 公佈了位於本斯海姆的新生產基地和新總部藍圖。 Sanner 專注於固態藥品塑膠包裝和液體初級包裝，處於製藥領域乾燥劑包裝發展的前沿。此舉旨在擴大其在該地區的影響力，並有望促進該行業的成長。
  • 此外，聚氯乙烯和 PVDC（聚偏二氯乙烯）通常用作主要包裝材料，可保護藥品免受氧氣、異味、濕氣、水蒸氣穿透、污染和細菌的影響。這使得 PVC 和 PVDC 成為泡殼包裝的合適材料。其卓越的有機品質確保包裝食品和藥品的風味不受影響。 PVC 單膜可抵抗陽光和紫外線，在製造和分銷過程中抑制細菌的生長，並可作為防止污染的屏障。

亞太地區佔主要佔有率

  • 中國醫藥產業的強勁成長為該國醫藥包裝公司創造了龐大的商機。對於企業來說，探索滿足藥品包裝市場新需求的包裝概念變得非常重要。
  • 中國政府加速醫療體系轉型的政策預計將加速醫藥包裝產業的發​​展。此外，我國正積極升級醫藥包裝設備和材料，實現醫藥產品多元化，為醫藥包裝企業創造了新的機會。
  • 受製藥業成長和新興經濟體醫療保健服務改善的推動，日本藥品包裝市場的前景看好。塑膠、玻璃、紙張和鋁箔是該市場的主要材料。直接影響藥品包裝產業動態的新興趨勢包括對環保包裝的需求不斷成長、奈米包裝的使用增加以及吹灌封技術的日益採用。
  • 印度藥品包裝產業在過去幾年中取得了顯著成長。隨著科技創新和新療法的出現，製藥業這一領域還有進一步成長的空間。 COVID-19 大流行增強了高效包裝和分銷產品的需求。我們可能會期望更快地製造和分銷產品，甚至包括包裝。包裝公司將面臨新的壓力，需要加快速度並開發增加需求的解決方案。
  • 韓國是亞洲成長最快的製藥地區之一，並正在成為全球醫療保健創新的關鍵貢獻者。韓國近年來在新藥研發方面取得了快速進展。特別是近年來，韓國的新藥研發能力在全球醫藥和生技產業中處於領先地位。
  • 亞太地區的其他國家包括印尼、澳洲、新加坡、泰國和馬來西亞等幾個國家。該市場的推動因素包括國際合作夥伴關係的激增、生物相似藥的成長、成品出口以及強勁的學名藥市場。

醫藥包裝行業概況

在醫藥包裝市場，現有企業之間的競爭非常激烈。該市場較為分散，Amcor PLC、Schott AG、WestRock Company、Berry Global 和 Aptar Group Inc. 等多家主要公司均參與其中。公司正在透過產品發布、合作夥伴關係和投資來擴展業務。

  • 2024 年 5 月，醫藥塑膠包裝領域的主要企業Gerresheimer AG 宣布計畫收購 Bormioli Pharma。這項策略性舉措旨在將 Bormioli Pharma 的專業產品（例如雙室和兒童防護/TE 瓶蓋配件）整合到 Gerresheimer 的產品組合中，並加強其在藥品包裝領域的影響力。
  • 2024 年 1 月 Bormioli Pharmaceuticals 很快就會成為 Gerresheimer AG 的一部分，並與潔淨科技公司 Loop Industries 合作。為了滿足對永續包裝日益成長的需求，該合作夥伴關係旨在提供專門由 Loop PET 樹脂製成的包裝，這是一種源自回收資源的高品質材料。此舉凸顯了醫藥包裝領域對PET材料不斷成長的需求。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場洞察

  • 市場概況
  • 產業價值鏈分析
  • 產業吸引力－波特五力分析
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度
  • COVID-19 市場影響評估

第5章市場動態

  • 市場促進因素
    • 包裝監管標準和打擊仿冒品的嚴格規範
    • 奈米技術對新一代創新包裝解決方案的影響
  • 市場挑戰
    • 由於供應商議價能力而導致原物料成本波動

第6章 市場細分

  • 按材質
    • 塑膠
    • 玻璃
    • 其他材料
  • 依產品類型
    • 瓶子
    • 注射器
    • 管瓶/安瓿
    • 管子
    • 蓋子和塞子
    • 標籤
    • 其他產品類型
  • 按地區
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 其他歐洲國家
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 韓國
      • 其他亞太地區
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲
    • 中東/非洲
      • 阿拉伯聯合大公國
      • 沙烏地阿拉伯
      • 南非
      • 其他中東和非洲

第7章 競爭格局

  • 公司簡介
    • Amcor PLC
    • 3M Company
    • Schott AG
    • WestRock Company
    • Berry Global Group Inc.
    • McKesson Corporation
    • AptarGroup Inc.
    • Klockner Pentaplast Group
    • CCL Industries Inc.
    • FlexiTuff International Ltd
    • Gerresheimer AG
    • West Pharmaceutical Services Inc.
    • Becton, Dickinson and Company
    • Vetter Pharma International GmbH
    • Catalent Inc.
    • WL Gore & Associates Inc.
    • Nipro Corporation

第8章投資分析

第9章 市場機會及未來趨勢

簡介目錄
Product Code: 53455

The Pharmaceutical Packaging Market size is estimated at USD 102.10 billion in 2024, and is expected to reach USD 137.28 billion by 2029, growing at a CAGR of 6.10% during the forecast period (2024-2029).

Pharmaceutical Packaging - Market

Key Highlights

  • The pharmaceutical industry is growing worldwide, creating a need for packaging to treat communicable and non-communicable diseases. Therefore, the demand for packaging in pharmaceutical manufacturing is growing as it protects pharmaceuticals from damage, biological contamination, and external influences.
  • Increased demand for pharmaceuticals is associated with technological advancements in the industry and directly creates demand for bottles, vials, and other packaging solutions. Additionally, the growing demand for injectables is driving the growth of glass vials in the pharmaceutical industry. Strong demand for oncology and other high-potency drugs (such as antibody conjugates and fast-acting steroids) and increasing per capita spending on pharmaceuticals are expected to be key growth drivers.
  • The global demand scenario for pharmaceutical products has supported revenue generation in the packaging sector and is expected to continue during the forecast period. Overall, the pharmaceutical packaging market is projected to register a steady growth rate due to ongoing expansion and research and development to improve pharmaceutical packaging. Thus, demand is anticipated to increase significantly during the forecast period.
  • The plastic packaging industry faces rising polymer costs, making plastics more expensive. Additionally, the war between Ukraine and Russia has pushed prices up again. The demand for plastics and plastic products is increasing Y-o-Y. The lack of supply to keep up with the increase in demand is also one factor driving higher polymer prices, which is expected to hinder market growth.
  • Owing to the spread of COVID-19, the market is expected to grow significantly. Due to the COVID-19 pandemic, customers shifted toward online purchasing. The COVID-19 pandemic hit hard on expanding packaging materials in developing and developed countries. However, strong demand for sterilized pharmaceutical packaging encouraged investment in the landscape. Moreover, industry players expect the healthcare industry to show strong demand for packaging technology.

Pharmaceutical Packaging Market Trends

Plastic Packaging Holds a Significant Market Share

  • Plastic is one of the most popular materials for pharmaceutical packaging as it is more applicable, durable, flexible, and sustainable. Pharmaceutical packaging utilizes plastic bottles constructed from various materials, including polyvinyl chloride, polyethylene, polypropylene, and polystyrene. The industry uses transparent, durable, lightweight plastic to store and market.
  • Plastics are used for packaging blister packs, sachets, prefilled syringes and inhalers, parenteral solution pouches, and bottles. Materials used in pharmaceutical packaging need to be chemically inert, have low permeability to water vapor, and are easy to handle. In addition, packaging materials come in direct contact with pharmaceuticals and biological agents and, hence, need to comply with strict regulations from regulatory authorities. Plastics and polymers meet these requirements; therefore, they are often used in pharmaceutical packaging.
  • Bottles for pharmaceutical packaging consist of child-resistant caps and closures. The US FDA requires pharmaceutical plastic manufacturers to highlight "child-resistant packaging" on product labels for consumer evaluation. Rising demand for child-safe packaging is one of the factors driving the pharmaceutical plastic packaging market during the forecast period.
  • Companies are focused on expanding their business as part of leveraging pharmaceutical packaging. For instance, in September 2024, Germany-based healthcare packaging firm Sanner unveiled blueprints for a fresh production site and its new headquarters in Bensheim. Specializing in plastic packaging for solid medications and single-dose primary packaging for liquids, Sanner has been at the forefront of promoting desiccant packaging in the pharmaceutical realm. This move to expand its presence in the region is poised to catalyze growth in the sector under scrutiny.
  • Moreover, polyvinyl chloride and PVDC (polyvinylidene chloride), commonly used as principal packaging materials, protect pharmaceutical items from oxygen and odor, moisture, water vapor transmission, contamination, and bacteria. This makes PVC and PVDC the preferred materials for blister packing. Their superior organoleptic qualities ensure that the flavor of packaged food and medications remains unaffected. PVC mono films are sunlight and UV-ray-resistant and serve as a barrier against contamination by halting the spread of germs during production and distribution.

Asia-Pacific to Occupy Major Share

  • The robust growth of the Chinese pharmaceutical sector creates significant business opportunities for the country's pharmaceutical packaging companies. It is now becoming critical for companies to look for packaging concepts that meet emerging needs in the pharmaceutical packaging market.
  • The Chinese government's policies to accelerate the transformation of the country's medical regime are expected to promote the development of the pharmaceutical packaging sector. Furthermore, China is actively upgrading its pharmaceutical packaging facilities and materials and diversifying its pharmaceutical products, bringing new opportunities to pharmaceutical packaging firms.
  • The future of the pharmaceutical packaging market in Japan looks good, driven by the pharmaceutical industry's growth and improving healthcare services in developing economies. In this market, plastic, glass, paper, and aluminum foil are the main material types. Emerging trends directly impacting the dynamics of the pharmaceutical packaging industry include rising demand for eco-friendly packaging, increasing use of nano-enabled packaging, and increasing adoption of blow-fill-seal technology.
  • The pharmaceutical packaging industry in India has been experiencing substantial growth for several years. Due to innovations and emerging treatments, there is room for further growth in this section of the pharma industry. The COVID-19 pandemic has brought a new awareness of the need to package and distribute products efficiently. There will be expectations to manufacture and distribute products quicker, right down to the packaging. Packaging companies will face new pressures to develop solutions to get things moving faster and increase demand.
  • South Korea is one of the fastest-growing pharma regions in Asia, emerging as a critical contributor to global healthcare innovation. It has tremendously advanced new drug research and development in the last few years. Especially during the past few years, Korea has developed new drug R&D capabilities in the global pharmaceutical and biotech landscape.
  • The scope of the Rest of Asia-Pacific includes multiple countries, such as Indonesia, Australia, Singapore, Thailand, and Malaysia. The market is driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations, and a robust generics market.

Pharmaceutical Packaging Industry Overview

The rivalry among the existing players is intense in the pharmaceutical packaging market. The market is fragmented with the presence of various major players, such as Amcor PLC, Schott AG, WestRock Company, Berry Global, and Aptar Group Inc. Companies are expanding their business through product launches, collaborations, and investments.

  • May 2024: Gerresheimer AG, a key player in the pharmaceutical plastic packaging sector, announced its acquisition plans for Bormioli Pharma. This strategic move aims to integrate Bormioli Pharma's specialized offerings, such as the Dual Chamber and Child Proof / TE Closures Accessories, into Gerresheimer's portfolio, bolstering its presence in the pharmaceutical packaging landscape.
  • January 2024: Bormioli Pharma, soon to be under the ownership of Gerresheimer AG, collaborated with Loop Industries, a clean technology firm. With a goal to meet the rising need for sustainable packaging, the collaboration is offering packaging made exclusively from Loop PET resin, a high-quality material sourced from recycled sources. This move underscores the growing demand for PET materials in the pharmaceutical packaging sector.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumption and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitutes
    • 4.3.5 Degree of Competition
  • 4.4 Assessment of Impact of the COVID-19 on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Regulatory Standards on Packaging and Stringent Norms Against Counterfeit Products
    • 5.1.2 Impact of Nanotechnology due to Innovative and New- generation Packaging Solutions
  • 5.2 Market Challenges
    • 5.2.1 Fluctuations in Raw Material Cost Due to Suppliers Bargaining Power

6 MARKET SEGMENTATION

  • 6.1 By Material
    • 6.1.1 Plastics
    • 6.1.2 Glass
    • 6.1.3 Other Materials
  • 6.2 By Product Type
    • 6.2.1 Bottles
    • 6.2.2 Syringes
    • 6.2.3 Vials and Ampoules
    • 6.2.4 Tubes
    • 6.2.5 Caps and Closures
    • 6.2.6 Labels
    • 6.2.7 Other Product Types
  • 6.3 By Geography
    • 6.3.1 North America
      • 6.3.1.1 United States
      • 6.3.1.2 Canada
    • 6.3.2 Europe
      • 6.3.2.1 Germany
      • 6.3.2.2 United Kingdom
      • 6.3.2.3 France
      • 6.3.2.4 Italy
      • 6.3.2.5 Spain
      • 6.3.2.6 Rest of Europe
    • 6.3.3 Asia-Pacific
      • 6.3.3.1 China
      • 6.3.3.2 Japan
      • 6.3.3.3 India
      • 6.3.3.4 South Korea
      • 6.3.3.5 Rest of Asia-Pacific
    • 6.3.4 Latin America
      • 6.3.4.1 Brazil
      • 6.3.4.2 Mexico
      • 6.3.4.3 Rest of Latin America
    • 6.3.5 Middle East and Africa
      • 6.3.5.1 United Arab Emirates
      • 6.3.5.2 Saudi Arabia
      • 6.3.5.3 South Africa
      • 6.3.5.4 Rest of Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Amcor PLC
    • 7.1.2 3M Company
    • 7.1.3 Schott AG
    • 7.1.4 WestRock Company
    • 7.1.5 Berry Global Group Inc.
    • 7.1.6 McKesson Corporation
    • 7.1.7 AptarGroup Inc.
    • 7.1.8 Klockner Pentaplast Group
    • 7.1.9 CCL Industries Inc.
    • 7.1.10 FlexiTuff International Ltd
    • 7.1.11 Gerresheimer AG
    • 7.1.12 West Pharmaceutical Services Inc.
    • 7.1.13 Becton, Dickinson and Company
    • 7.1.14 Vetter Pharma International GmbH
    • 7.1.15 Catalent Inc.
    • 7.1.16 W. L. Gore & Associates Inc.
    • 7.1.17 Nipro Corporation

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS